Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomonori Yamanishi

Showing results (1-10 of 135) with videos related to

Pageof 14
Sort By:
Neurourology and Urodynamics|July 30, 2020
Bladder sensation evaluation of a carrageenan-induced chronic prostatitis model using a direct measurement of the bladder mechanosensitive single-unit afferent nerve activityNaoki Aizawa, Tomonori Yamanishi, Tomoe Fujita
International Journal of Urology : Official Journal of the Japanese Urological Association|June 5, 2008
Neuromodulation for the treatment of urinary incontinenceTomonori Yamanishi, Takao Kamai, Ken-ichiro Yoshida
Urology|December 21, 2002
Muscarinic receptor subtypes and management of the overactive bladderChristopher R Chapple, Tomonori Yamanishi, Russell Chess-Williams
International Journal of Urology : Official Journal of the Japanese Urological Association|May 4, 2017
Efficacy and safety of combination therapy with tamsulosin, dutasteride and imidafenacin for the management of overactive bladder symptoms associated with benign prostatic hyperplasia: A multicenter, randomized, open-label, controlled trial (DIrecT Study)Tomonori Yamanishi, Hirotaka Asakura, Narihito Seki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 17, 2018
Mirabegron or tolterodine for the treatment of overactive bladder in Japan: Which drug is more cost-effective as the first-line treatment?Yuriko Yamanishi, Tomonori Yamanishi, Hakujyu Tajima, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|September 10, 2008
Sphincter EMG as a diagnostic tool in autonomic disordersRyuji Sakakibara, Tomoyuki Uchiyama, Tomonori Yamanishi, et al.
Journal of Endourology|July 29, 2008
Three-dimensional image processing system for the ureter and urethra using endoscopic videoTatsuo Igarashi, Satoki Zenbutsu, Tomonori Yamanishi, et al.
Neurourology and Urodynamics|December 25, 2003
Lower urinary tract dysfunctions in patients with spinal cord tumorsTomoyuki Uchiyama, Ryuji Sakakibara, Takamichi Hattori, et al.
Lower Urinary Tract Symptoms|October 26, 2018
A 52-week multicenter randomized controlled study of the efficacy and safety of add-on dutasteride and imidafenacin to tamsulosin in patients with benign prostatic hyperplasia with remaining overactive bladder symptoms (DIrecT study)Tomonori Yamanishi, Hirotaka Asakura, Narihito Seki, et al.
Urologia Internationalis|March 10, 2021
Triple Therapy with Tamsulosin, Dutasteride, and Imidafenacin for Benign Prostatic Hyperplasia in Patients with Overactive Bladder Symptoms Refractory to Tamsulosin: Subgroup Analyses of the DIrecT StudyTomonori Yamanishi, Hirotaka Asakura, Narihito Seki, et al.
Pageof 14

Showing results (1-10 of 135) with videos related to

Sort By:
Pageof 14
Neurourology and Urodynamics|July 30, 2020
Bladder sensation evaluation of a carrageenan-induced chronic prostatitis model using a direct measurement of the bladder mechanosensitive single-unit afferent nerve activityNaoki Aizawa, Tomonori Yamanishi, Tomoe Fujita
International Journal of Urology : Official Journal of the Japanese Urological Association|June 5, 2008
Neuromodulation for the treatment of urinary incontinenceTomonori Yamanishi, Takao Kamai, Ken-ichiro Yoshida
Urology|December 21, 2002
Muscarinic receptor subtypes and management of the overactive bladderChristopher R Chapple, Tomonori Yamanishi, Russell Chess-Williams
International Journal of Urology : Official Journal of the Japanese Urological Association|May 4, 2017
Efficacy and safety of combination therapy with tamsulosin, dutasteride and imidafenacin for the management of overactive bladder symptoms associated with benign prostatic hyperplasia: A multicenter, randomized, open-label, controlled trial (DIrecT Study)Tomonori Yamanishi, Hirotaka Asakura, Narihito Seki, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 17, 2018
Mirabegron or tolterodine for the treatment of overactive bladder in Japan: Which drug is more cost-effective as the first-line treatment?Yuriko Yamanishi, Tomonori Yamanishi, Hakujyu Tajima, et al.
Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society|September 10, 2008
Sphincter EMG as a diagnostic tool in autonomic disordersRyuji Sakakibara, Tomoyuki Uchiyama, Tomonori Yamanishi, et al.
Journal of Endourology|July 29, 2008
Three-dimensional image processing system for the ureter and urethra using endoscopic videoTatsuo Igarashi, Satoki Zenbutsu, Tomonori Yamanishi, et al.
Neurourology and Urodynamics|December 25, 2003
Lower urinary tract dysfunctions in patients with spinal cord tumorsTomoyuki Uchiyama, Ryuji Sakakibara, Takamichi Hattori, et al.
Lower Urinary Tract Symptoms|October 26, 2018
A 52-week multicenter randomized controlled study of the efficacy and safety of add-on dutasteride and imidafenacin to tamsulosin in patients with benign prostatic hyperplasia with remaining overactive bladder symptoms (DIrecT study)Tomonori Yamanishi, Hirotaka Asakura, Narihito Seki, et al.
Urologia Internationalis|March 10, 2021
Triple Therapy with Tamsulosin, Dutasteride, and Imidafenacin for Benign Prostatic Hyperplasia in Patients with Overactive Bladder Symptoms Refractory to Tamsulosin: Subgroup Analyses of the DIrecT StudyTomonori Yamanishi, Hirotaka Asakura, Narihito Seki, et al.
Pageof 14